SUBSCRIBE
SUBSCRIBE

Elizabeth Glasure

Business
The Next Big Thing in Birth Control: Amphora Offers Women a Missing Option
Amphora is a viscous and bioadhesive contraceptive, packaged in a prefilled applicator.
January 22, 2020
 · 
3 min read
 · 
Elizabeth Glasure
Job Trends
Treatment Options for Diabetes Continue to Grow and Expand
Effective treatments for diabetes are becoming more and necessary. The past few years have demonstrated productive strides in drug therapies, such as following medications.
November 25, 2019
 · 
4 min read
 · 
Elizabeth Glasure
Business
Up-and-Coming Female Powerhouses of Biotech
Balancing slim chances with a drive for success, each of these women beat the biotech odds.
November 19, 2019
 · 
3 min read
 · 
Elizabeth Glasure
lucarista / Shutterstock
Tecentriq Continues Upward Projection by Proving Efficacy Over and Over
The versatile drug currently treats locally advanced or metastatic urothelial carcinoma, metastatic non-small cell lung cancer, metastatic triple-negative breast cancer, and extensive-stage small cell lung cancer.
November 4, 2019
 · 
3 min read
 · 
Elizabeth Glasure
BioMidwest
Scientists Can Now Mass-Produce Primitive Human Embryoids
Scientists from the University of Michigan have created a device that can mass-produce human embryo-like structures, according to a recent NPR report. The synthetic, living objects closely resemble a primitive form of human embryos.
September 27, 2019
 · 
4 min read
 · 
Elizabeth Glasure
MM Patients Experience Longer Progression-Free Survival with REVLIMID
REVLIMID, or lenalidomide, describes itself as “a new chemotherapy-free treatment combination.”
September 26, 2019
 · 
4 min read
 · 
Elizabeth Glasure
CL Shebley / Shutterstock
IMBRUVICA Treats CLL and SLL Patients Without Chemotherapy
IMBRUVICA is a once-daily oral therapy, and describes itself as working differently than other treatments such as chemotherapy.
September 24, 2019
 · 
4 min read
 · 
Elizabeth Glasure
Business
Biotech Youth Training Program to be Offered in India
The Tribune India has recently announced that the Department of Biotechnology will be training “unemployed youth in tools and techniques in the area of biotechnology within a period of three years.”
July 29, 2019
 · 
4 min read
 · 
Elizabeth Glasure
Job Trends
Zero Gravity May Allow Viable Human Organs to be 3D Printed
“Our ultimate goal is to provide a solution to an organ shortage that causes an average of 20 people per day in the U.S. alone to die waiting for an organ transplant,” quoted Rich Boling, the vice-president of corporate advancement at Techshot.
July 23, 2019
 · 
4 min read
 · 
Elizabeth Glasure
Mavacamten is showing top of the line results in p
Business
A Mathematical Model Makes Earlier Detection of CVD Possible
Early detection of cardiovascular disease is becoming possible due to research from Giovanna Guidoboni, Marjorie Skubic and a team at the University of Missouri.
May 15, 2019
 · 
4 min read
 · 
Elizabeth Glasure
MikeDotta / Shutterstock
Genetown
Of Mice and Men: New Light and Sound Combination Therapy May Treat Alzheimer’s
Recently published research by MIT neuroscientists indicates that amyloid plaques could be reduced via brain wave stimulation.
April 19, 2019
 · 
4 min read
 · 
Elizabeth Glasure
Business
A Journey to Wireless Neural Activity Modulation, Featuring Dr. Polina Anikeeva
Dr. Anikeeva, a neural engineer, is an Associate Investigator at the McGovern Institute for Brain Research at Massachusetts Institute of Technology (MIT). She’s an Associate Professor of Materials Science, Engineering, and Brain and Cognitive Sciences as well as an Associate Director of the Research Laboratory of Electronics.
February 12, 2019
 · 
5 min read
 · 
Elizabeth Glasure
Deals
In 2018, Life Sciences Industry Fell Behind on Projections for M&A Activity
In 2018 alone, mergers and acquisitions (M&A) activity among the life sciences industry totaled US$198B according to the 2019 EY M&A Firepower Report. The report continues on to state that “Life sciences M&A in 2018 was strong but failed to meet market expectations as companies focused on portfolio optimization.”
January 15, 2019
 · 
4 min read
 · 
Elizabeth Glasure
Business
New Targeted Cancer Therapies Prove Successful When Chemo Does Not
In a special report published by Reuters last month, Michele Gershberg describes the painstaking medical journey of her 4-year-old son. “It was March 2017. Over the previous year, the signs had mounted that something was wrong.”
January 7, 2019
 · 
4 min read
 · 
Elizabeth Glasure
Pharm Country
Artificial Intelligence Is the Next Big Player in Genomics
According to consultant firm Frost & Sullivan, artificial intelligence (AI) systems will be the next big players in both global healthcare and individual gene editing. By 2021, the firm predicts that AI will be responsible for 6.7 billion dollars in revenue.
December 10, 2018
 · 
4 min read
 · 
Elizabeth Glasure
Load More